Get the Stockscreener App
1.08
16.92%
-0.22
After Hours:
1.13
0.05
+4.63%
Aditxt Inc stock is traded at $1.08, with a volume of 204.62K.
It is down -16.92% in the last 24 hours and down -73.53% over the past month.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
See More
Previous Close:
$1.30
Open:
$1.29
24h Volume:
204.62K
Relative Volume:
0.76
Market Cap:
$559.28K
Revenue:
$5,900
Net Income/Loss:
$-43.10M
P/E Ratio:
-0.000025
EPS:
-43955.671
Net Cash Flow:
$-22.59M
1W Performance:
-33.33%
1M Performance:
-73.53%
6M Performance:
-99.88%
1Y Performance:
-99.99%
1-Day Range:
$1.03
$1.32
1-Week Range:
$1.03
$1.60
52-Week Range:
$1.03
$8,362.00
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909-488-0844
Address
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, INSM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
1.08 | 673.21K | 5,900 | -43.10M | -22.59M | -43,955.67 |
VRTX
Vertex Pharmaceuticals Inc
|
451.24 | 115.33B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
736.53 | 77.48B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
681.85 | 41.09B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
306.66 | 41.40B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
143.98 | 29.32B | 606.42M | -1.28B | -997.58M | -6.403 |
Aditxt Inc Stock (ADTX) Latest News
Travel Stocks: Should value investors consider Aditxt IncEarnings Growth Report & Proven Capital Preservation Methods - baoquankhu1.vn
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
Aug Technicals: Can Aditxt Inc grow without dilutionCPI Data & Daily Entry Point Trade Alerts - baoquankhu1.vn
Aditxt acquires Ignite Proteomics to expand precision oncology capabilities - MSN
IMAC Surrenders Ignite Assets; Proposed $35 Million Sale to Aditxt and $36 Million Financing - TradingView
IMAC Holdings (BACK) gives up Ignite assets to satisfy defaulted notes and links $36M ADTX preferred deal - Stock Titan
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary - Investing.com
Aditxt names Jeff Busch CEO of Ignite Proteomics subsidiary By Investing.com - Investing.com UK
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer - marketscreener.com
Aditxt’s cancer-therapy unit hires public company veteran Jeff Busch - Stock Titan
Targets Report: What are the risks of holding Aditxt Inc2026 Snapshot & Safe Swing Trade Setup Alerts - baoquankhu1.vn
ADTX Technical Analysis | Trend, Signals & Chart Patterns | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Sahm
Aditxt Finalizes Ignite Proteomics Acquisition, Strengthening Oncology Focus - The Globe and Mail
Aditxt acquires precision oncology firm Ignite Proteomics By Investing.com - Investing.com South Africa
Aditxt (ADTX) Acquires Ignite Proteomics, Shares Drop 37% - GuruFocus
Aditxt Backs Acquisition of Ignite Proteomics - themiddlemarket.com
Aditxt acquires precision oncology firm Ignite Proteomics - Investing.com Nigeria
Aditxt (ADTX) Acquires Ignite Proteomics in $36M Stock Deal - GuruFocus
Aditxt Buys Ignite Proteomics for $36M in Preferred Stock and Secures $2.88M Note Financing - TradingView
Aditxt (NASDAQ: ADTX) buys Ignite Proteomics with $36M preferred stock, adds notes - Stock Titan
Aditxt cancer move: Ignite Proteomics to guide therapy for 600,000 - Stock Titan
Aditxt, Inc. acquired Ignite Proteomics LLC from IMAC Holdings, Inc. and others for approximately $36 million. - marketscreener.com
Aditxt to implement 1-for-8 reverse stock split on March 9 - Investing.com Nigeria
ETF Watch: Does Aditxt Inc stock benefit from AI growth2025 Analyst Calls & Weekly Top Performers Watchlists - baoquankhu1.vn
Aditxt Implements Reverse Stock Split to Maintain Nasdaq Listing - The Globe and Mail
Guidance Update: Is Aditxt Inc forming a bullish divergenceWall Street Watch & Weekly Watchlist of Top Performers - baoquankhu1.vn
Aditxt (ADTX) Implements 1-for-8 Reverse Stock Split - GuruFocus
Aditxt, Inc. (Nasdaq Adtx) announces 1-for-8 reverse stock split effective at the open of trading on March 9, 2026 - marketscreener.com
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026 - marketscreener.com
Aditxt (NASDAQ: ADTX) sets 1-for-8 reverse stock split to support Nasdaq bid - Stock Titan
Eight Aditxt shares become one as 1-for-8 Nasdaq reverse split starts March 9 - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
VIX Spike: Can Aditxt Inc grow without dilutionTrade Analysis Summary & Technical Pattern Recognition Alerts - baoquankhu1.vn
ADTX SEC FilingsAditxt Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ADTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Comparing Aditxt (NASDAQ:ADTX) & Ernexa Therapeutics (NASDAQ:ERNA) - Defense World
ADTX Fundamental Analysis | ADITXT INC (NASDAQ:ADTX) - ChartMill
Can Aditxt Inc grow without external fundingMarket Volume Report & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Is Aditxt Inc. stock a good dividend stockJuly 2025 Setups & AI Optimized Trade Strategies - mfd.ru
Aug Update: What are the risks of holding Aditxt IncEarnings Trend Report & Smart Money Movement Alerts - baoquankhu1.vn
Does Aditxt Inc. stock benefit from AI growthJuly 2025 EndofMonth & Capital Efficient Trade Techniques - mfd.ru
Aug Momentum: Will TNL Mediagene be affected by tariffsPortfolio Risk Report & Pattern Based Trade Signal System - baoquankhu1.vn
ADTX Technical Analysis & Stock Price Forecast - Intellectia AI
Will Aditxt Inc. stock remain a Wall Street favoriteMarket Growth Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
Aditxt Holders Approve Share Issuances, Reverse Split Flexibility - The Globe and Mail
Does Aditxt Inc. have pricing powerJuly 2025 Earnings & Verified Chart Pattern Signals - mfd.ru
ADTX PE Ratio & Valuation, Is ADTX Overvalued - Intellectia AI
Aditxt Inc. Completes Reverse Split, Stock Price Drops - Intellectia AI
Fiserv Introduces INDX, a Real-Time Cash Settlement Platform for Digital Asset Companies - The Globe and Mail
What is Aditxt Inc. s debt to equity ratioJuly 2025 Selloffs & Weekly Setup with ROI Potential - mfd.ru
Aditxt Inc Stock (ADTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):